Welcome To Latest IND >> Fastest World News
.
Cipla
has announced an exclusive licensing agreement with Taiwan-based Formosa Pharmaceuticals to market
clobetasol propionate ophthalmic suspension
0.05% (APP13007) across 11 countries, including India. It is used to treat post-op inflammation and pain following ocular surgery.
Stay informed with the latest business news, updates on bank holidays and public holidays.
Latest IND